Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11577 - 11584 of 12085 results

The New York Wage Theft Prevention Act's Annual Pay Notice Deadline is Just Around the Corner
December 12, 2011| Blog| Viewpoint

The PROTECT IP ACT and the STOP ONLINE PIRACY ACT (SOPA): New Solutions to Stop Online Infringement and Piracy
December 12, 2011| Blog| Viewpoint

ML Strategies Posts Weekly Health Care Reform Update, December 5, 2011
December 6, 2011| Blog| Viewpoint

Trademark Enforcement, Trademark "Bullies" and Social Media
December 5, 2011| Blog| Viewpoint

Lawsuit Filed Over .XXX Domain Name Launch: Could More Lawsuits Follow?
December 1, 2011| Blog| Viewpoint

FTC: Facebook "Deceived" Consumers by Failing to Keep Privacy Promises
November 30, 2011| Blog| Viewpoint

OIG Questions Laboratory Management Arrangement in Advisory Opinion 11-17
November 29, 2011| Blog| Viewpoint

Rockford Rerun: FTC Sues to Stop Hospital Merger
November 28, 2011| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
